China's All-powerful Development Commission Mandates New Round Of Drug Price Cuts
This article was originally published in PharmAsia News
Executive Summary
Some drug companies and associations recently received the National Development and Reform Commission's "Drug Price Control Measures" document, which reveals a new round of essential drug price adjustments